SKINBIOTHERAPEUTICS PLC (SBTX) — Investor Presentation

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the SKINBIOTHERAPEUTICS PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Just simply type in your questions and press send. Before we begin, I would like to submit the following poll. And I would now like to hand you over to Acting Chair, Alison Levitt. Good morning to you. Good morning. Welcome, everybody, to this morning's presentation from SKINBIOTHERAPEUTICS. I'm Alison Levitt, and I'm the Acting Chair of the company, and I joined the Board at the beginning of January twenty twenty six. I'm accompanied this morning by Rachel Parsonage, Interim CEO, who was appointed in March of this year. Morning, everyone. As a reminder to those of you who might not know the company, SKINBIOTHERAPEUTICS is a life sciences company focused on skin health. Next slide. Please see our disclaimer. So this slide is an overview of what we will be covering today. The normal half year results process was significantly disrupted. So before we talk about half year twenty six results, I want to cover what happened post period end and the chain of events that ensued. We will then talk through the adjustments that have been made to the last year's restated FY 2025 accounts. And then Rachel will take us through the operational and financial highlights of the first half of FY 2026. She will also cover how the business has traded in the second half of the financial year. As we said in the recently published results, we started the new financial year with optimism. But in February 2026, there was significant disruption to the business, which I'll go through now. This slide reflects...